Although it is currently unknown whether miRNA-146a-5p possesses oncogenic properties in GBM cells, results obtained in breast cancer tissue and MCF-7 cell line support this role through the BRCA1 pathways [36]. The gene discussed is BRCA1; the disease is glioblastoma.